$ETBI EastGate Biotech Provides Summary of 2019 Corporate and Development Highlights https://finance.yahoo.com/news/eastgate-biotech-provides-summary-2019-140010407.html?soc_src=hl-viewer&soc_trk=tw via @YahooFinance
$ETBI EastGate Biotech Pakistan Receives International Marketing Rights of Anaferon an Approved Coronavirus Treatment to Potentially Combat the Wuhan Coronavirus https://www.otcmarkets.com/stock/ET...oved-Coronavirus-Treatment-to-Poten?id=252661
ETBI EastGate Biotech Discusses Their Phase 3 Clinical Trials and Recent Coronavirus Agreement The Stock Day Podcast welcomed EastGate Biotech (OTC Pink: ETBI) ("the Company"), a company that focuses on innovative technological developments and produces and distributes innovative drug compounds and healthy nutraceuticals that are based on natural therapies absorbed by the body. CEO of the Company, Anna Gluskin, and President of the Company, Rose Perri, joined Stock Day host Everett Jolly. https://www.otcmarkets.com/stock/ETBI/news/story?e&id=1525233 To hear EastGate Biotech's entire interview, follow the link to the podcast here: https://audioboom.com/posts/7496606-eastgate-biotech-discusses-their-phase-3-clinical-trials-and-recent-coronavirus-agreement
$ETBI EastGate Biotech Pakistan Expands its Collaboration in Advancing the Development of a New Vaccine Against COVID-19. Joint Venture Collaboration to also pursue antibiotic products to create a pipeline to fight various new strains of flu illnesses https://www.otcmarkets.com/stock/ET...t-of-a-New-Vaccine-Against-COVID-19?id=254133
